Reimbursement

Insulin prices are 8 times higher in the United States than 32 other high-income countries combined.

Pharmacy Times® interviewed Nancy Lyons, BSPharm, MBA, CDE, vice president and chief pharmacy officer for Health Mart, and Pete Slone, senior vice president of public affairs for McKesson, on the importance of payment models that reward pharmacists’ commitment to patient services.

During American Pharmacists Month, and as the country uses all available health care resources to address COVID-19, there has never been a better or more important time to grant provider status to pharmacists.

An overview of arrangements that pharmacies enter into that violate the federal anti-kickback statute.

A study published in The Lancet Public Health found that modifiable health risks, such as obesity, high blood pressure, and smoking, were linked to more than $730 billion in health care spending in the United States in 2016. 

The Provider Relief Fund, as part of the CARES Act, was an important stopgap for many health care providers across the country, but details on reporting requirements and timing have been elusive.
 

Technology can help revolutionize how a pharmacy manages patients, collects payments, communicates, and can improve overall efficiency.

Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.

Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.

During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.

Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.

The terms of participation in the phase 2 round of the Provider Relief Fund created an unintended exclusion for pharmacies that primarily serve Medicaid/Children’s Health Insurance Program patients.